GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biomed Co Ltd (XKRX:214610) » Definitions » Capital Expenditure

Biomed Co (XKRX:214610) Capital Expenditure : ₩-8,643.47 Mil (TTM As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Biomed Co Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Biomed Co's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₩-8,533 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-8,643.47 Mil.


Biomed Co Capital Expenditure Historical Data

The historical data trend for Biomed Co's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomed Co Capital Expenditure Chart

Biomed Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6,022.24 -3,131.08 -1,660.55 -681.29 -986.79

Biomed Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -876.36 366.97 -226.72 -250.67 -8,533.05

Biomed Co Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,643.47 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomed Co Business Description

Traded in Other Exchanges
N/A
Address
815, Daewangpangyo-ro, Sujeong-gu, Gyeonggi-do, Seongnam-si, KOR
Biomed Co Ltd Formerly MiCo BioMed Co Ltd is engaged in developing Bio-Diagnostic Labchip technology, efficient bio-reagents, and portable mini High-Speed diagnostic equipment. It also manufactures medical device and precision instrument.

Biomed Co Headlines

No Headlines